Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,115.70
-7.3000-0.65%
Post-market: 1,116.350.6500+0.06%17:51 EDT
Volume:1.84M
Turnover:2.05B
Market Cap:1.05T
PE:37.45
High:1,131.44
Open:1,129.41
Low:1,113.29
Close:1,123.00
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.82
T/O Rate:0.20%
Dividend:6.69
Dividend Rate:0.60%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.13
PE(LYR):48.61

Loading ...

Eli Lilly Nears Agreement to Acquire Psychedelic Drug Developer Atai Beckley

Deep News
·
Jul 16

AtaiBeckley jumps 55% after report of Eli Lilly takeover interest

TIPRANKS
·
Jul 16

Eli Lilly close to acquisition of AtaiBeckley, Bloomberg reports

TIPRANKS
·
Jul 16

Lilly Said to Near Deal for Psychedelic Drugmaker Ataibeckley- Bloomberg News

THOMSON REUTERS
·
Jul 16

AI is so Big, It's Now Impossible for Investors to Avoid

Dow Jones
·
Jul 16

Novo Nordisk Wins EU Approval for Wegovy Weight-loss Pill

Reuters
·
Jul 16

Eli Lilly is Maintained at Buy by Citigroup

Dow Jones
·
Jul 15

This Wall Street 'theme-o-meter' Has a Clear Message: the Artificial-intelligence Bull Market is Back

Dow Jones
·
Jul 15

VivoSim Receives $5 Million Eli Lilly Milestone Payment, Issues Fiscal 2027 Revenue Growth Outlook

MT Newswires Live
·
Jul 15

VivoSim receives $5M milestone payment from Eli Lilly

TIPRANKS
·
Jul 15

Vivosim Labs - Eligible for up to $45 Mln in Additional Milestone Payments from Eli Lilly

THOMSON REUTERS
·
Jul 15

Market Chatter: Eli Lilly-Backed AdvanCell Raises $315 Million From New Funding Round

MT Newswires Live
·
Jul 15

Citigroup Adjusts Price Target on Eli Lilly to $1,600 From $1,500, Maintains Buy Rating

MT Newswires Live
·
Jul 15

Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up

Deep News
·
Jul 15

In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's

Dow Jones
·
Jul 15

Eli Lilly Wins Full FDA Approval for Selpercatinib in Solid Tumors

MT Newswires Live
·
Jul 15

Retevmo granted FDA traditional approval for RET fusion-positive solid tumors

TIPRANKS
·
Jul 15

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic Ret Fusion-positive Solid Tumors

THOMSON REUTERS
·
Jul 15

Eli Lilly is Maintained at Outperform by Bernstein

Dow Jones
·
Jul 14

Eli Lilly : Bernstein Raises Target Price to $1385 from $1300

THOMSON REUTERS
·
Jul 14